Versant Venture Capital IV, L.P.
Related Filers (28)
- Versant Side Fund IV, L.P. (26)
- Versant Ventures IV, LLC (24)
- Versant Ventures VI GP, L.P. (11)
- Versant Venture Capital VI, L.P. (11)
- Versant Ventures VI GP-GP, LLC (11)
- CRISPR Therapeutics AG (9)
- Oyster Point Pharma, Inc. (9)
- Versant Vantage I GP, L.P. (9)
- Versant Vantage I, L.P. (9)
- Versant Vantage I GP-GP, LLC (9)
- Versant Venture Capital V, L.P. (5)
- Versant Venture Capital V (Canada), LP (5)
- Versant Ophthalmic Affiliates I, L.P. (4)
- Versant Affiliates Fund V, L.P. (4)
- Clovis Oncology, Inc. (3)
- IVERIC bio, Inc. (3)
- Inari Medical, Inc. (3)
- Tempest Therapeutics, Inc. (2)
- Versant Capital IV (Switzerland) GmbH (1)
- Versant IV Luxco S.a r.l. (1)
- Adverum Biotechnologies, Inc. (1)
- Audentes Therapeutics, Inc. (1)
- Versant Ventures V, LLC (1)
- Versant Ventures V (Canada), L.P. (1)
- MINERVA SURGICAL INC (1)
- Versant Vantage II GP-GP, LLC (1)
- Versant Vantage II GP, L.P. (1)
- Versant Vantage II, L.P. (1)
- Show More ...
Ownership (32)
4
Wednesday, 1/4/2023
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/3/2022
Tempest Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 2/11/2022
MINERVA SURGICAL INC: Major Shareholders
4
Friday, 1/7/2022
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/23/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/20/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 7/6/2021
Tempest Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 5/14/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/30/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/19/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/19/2020
Inari Medical, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 9/18/2020
CRISPR Therapeutics AG: Major Shareholders
4
Tuesday, 6/23/2020
IVERIC bio, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/27/2020
Inari Medical, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 5/21/2020
Inari Medical, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 11/4/2019
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/30/2019
Oyster Point Pharma, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Friday, 6/28/2019
CRISPR Therapeutics AG: Major Shareholders
4
Wednesday, 1/16/2019
Ophthotech Corp.: Statement of changes in beneficial ownership of securities
3
Friday, 11/9/2018
Ophthotech Corp.: Initial statement of beneficial ownership of securities
4
Tuesday, 4/24/2018
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 9/15/2017
CRISPR Therapeutics AG: Major Shareholders
4
Thursday, 9/7/2017
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4/A
Friday, 12/23/2016
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
SC 13D
Thursday, 11/3/2016
CRISPR Therapeutics AG: Major Shareholders
4
Wednesday, 10/26/2016
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/18/2016
CRISPR Therapeutics AG: Initial statement of beneficial ownership of securities
3
Tuesday, 7/19/2016
Audentes Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Wednesday, 5/18/2016
Adverum Biotechnologies, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/5/2013
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/17/2011
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 11/15/2011
Clovis Oncology, Inc.: Initial statement of beneficial ownership of securities